课题基金 / 基金详情

AGE-RELATED CHANGES IN BONE MORPHOLOGY ARE ACCELERATED IN GROUP VIA

AGE-RELATED CHANGES IN BONE MORPHOLOGY ARE ACCELERATED IN GROUP VIA
VIA 组中与年龄相关的骨形态变化加速
批准号:
7954015
负责人:
SASANKA RAMANADHAM
金额:
$0.56万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-02-01 至 2010-01-31

项目摘要

项目成果

SASANKA RAMANADHAM的其他基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金, 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 磷脂酶A(2)(pla(2))能从磷脂中水解花生四烯酸等sn-2脂肪酸取代基,花生四烯酸代谢产物是公认的骨模型介体。我们先前已经通过pla(2)(ipla(2)beta)建立了缺乏该组的基因敲除(KO)小鼠,该基因参与了一系列信号事件;ipla(S)betamRNA在野生型(WT0)小鼠的骨骼中表达,但不在KO小鼠的骨骼中表达。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Phospholipases A(2) (PLA(2)) hydrolyze the sn-2 fatty acid substituent, such as arachidonic acid, from phospholipids, and arachidonate metabolites are recognized mediators of bone modeling. We have previously generated knockout (KO) mice lacking the group VIA PLA(2) (iPLA(2)beta), whcih participates in a variety of signaling events; iPLA(s)beta mRNA is expressed in bones of wild-type (WT0 but not KO mice.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Exploiting iPLA2β-modified macrophages as immunotherapy for T1D
Exploiting iPLA2β-modified macrophages as immunotherapy for T1D
Importance of immune-cell lipid signaling in events leading to type 1 diabetes
Contribution of β-Cell- & Immune Cell-Derived Lipids to β-Cell Death and Diabetes